Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Each component is a well-characterized peptide with an established chemical identity and published molecular structure
Compounded medications, research-only peptides, foreign-purchased products, unlabeled syringes, and powders can raise different screening, customs, pharmacy, or legal issues
Important limitation: Neither is FDA-approved, and human clinical data relies heavily on animal models and observational reports
Composition Cagrilintide: 5mg GLP-1 S: 5 mg Fill volume: 2 ml vial Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined pathway evaluation of amylin-receptorrelated and GLP-1receptor mechanisms in in-vitro or ex-vivo models Assay development, including chromatographic separation of two co-formulated peptides and blend ratio characterization Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing COA pending third-party verification in progress Lyophilized for transit stability
As with any form of aesthetic treatment, there are some risks associated with acne treatment including dryness and irritation of the skin, increased sensitivity to sunlight, and changes in skin pigmentation
Why BPC-157 Is Grouped With Regenerative Peptides BPC-157 is grouped within the regenerative research category alongside TB-500 and GHK-Cu because all three are studied for mechanisms with tissue-repair-adjacent implications not because they share a receptor or mechanism
US$ 22.85
US$ 24.64
US$ 26.03
US$ 20.98
US$ 28.94
US$ 24.67
)
